Casdin Partners GP, LLC's Form 4 filing
Standard Biotools Inc. (LAB) · filed May 17, 2024
- Accession no.
- 0000919574-24-003252
- Filed
- May 17, 2024, 8:11 PM ET
- Trade date
- May 15-17, 2024
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not checked
This filing lists 3 non-derivative transactions and 0 derivative transactions. Open-market purchases total $3.46M. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Casdin Partners GP, LLCCIK 0001534260 | Director, 10% Owner |
| Casdin Capital, LLCCIK 0001534261 | Director, 10% Owner |
| Casdin EliCIK 0001534264 | Director, 10% Owner |
| Casdin Partners Master Fund, L.P.CIK 0001534265 | Director, 10% Owner |
| Casdin Private Growth Equity Fund, L.P.CIK 0001823061 | Director |
| Casdin Private Growth Equity Fund GP, LLCCIK 0001864554 | Director |
| Casdin Private Growth Equity Fund II, L.P.CIK 0001891102 | Director |
| Casdin Private Growth Equity Fund II GP, LLCCIK 0001919480 | Director |
| Casdin Partners FO1-MSV, LPCIK 0001938709 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| May 15, 2024 | Common Stock | PPurchaseAcquired | +500,000 | $2.57 | +$1,282,550 | 44,523,749 | Indirect | |
| May 16, 2024 | Common Stock | PPurchaseAcquired | +500,000 | $2.54 | +$1,270,950 | 45,023,749 | Indirect | |
| May 17, 2024 | Common Stock | PPurchaseAcquired | +352,072 | $2.56 | +$902,043.67 | 45,375,821 | Indirect |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.